Búsqueda | Portal de Búsqueda de la BVS

1.

Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma.

Iwaki, Sho; Kadowaki, Shigenori; Honda, Kazunori; Narita, Yukiya; Masuishi, Toshiki; Taniguchi, Hiroya; Ando, Masashi; Muro, Kei; Sawabe, Michi; Suzuki, Hidenori; Nishikawa, Daisuke; Beppu, Shintaro; Terada, Hoshino; Kishikawa, Toshihiro; Kawakita, Daisuke; Hanai, Nobuhiro.

Int J Clin Oncol ; 29(6): 764-770, 2024 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-38555323

2.

Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).

Ando, Koji; Nakamura, Yoshiaki; Kitao, Hiroyuki; Shimokawa, Mototsugu; Kotani, Daisuke; Bando, Hideaki; Nishina, Tomohiro; Yamada, Takanobu; Yuki, Satoshi; Narita, Yukiya; Hara, Hiroki; Ohta, Takashi; Esaki, Taito; Hamamoto, Yasuo; Kato, Ken; Yamamoto, Yoshiyuki; Minashi, Keiko; Ohtsubo, Koushiro; Izawa, Naoki; Kawakami, Hisato; Kato, Takeshi; Satoh, Taroh; Okano, Naohiro; Tsuji, Akihito; Yamazaki, Kentaro; Yoshino, Takayuki; Maehara, Yoshihiko; Oki, Eiji.

Br J Cancer ; 129(6): 1032-1039, 2023 10.

Artículo en Inglés | MEDLINE | ID: mdl-37532830

3.

Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study.

Taniguchi, Hiroya; Yamazaki, Kentaro; Masuishi, Toshiki; Kawakami, Takeshi; Onozawa, Yusuke; Honda, Kazunori; Kadowaki, Shigenori; Narita, Yukiya; Tsushima, Takahiro; Hamauchi, Satoshi; Todaka, Akiko; Yokota, Tomoya; Ando, Masashi; Mori, Keita; Shirasu, Hiromichi; Yasui, Hirofumi; Muro, Kei.

Oncologist ; 28(11): e1108-e1113, 2023 Nov 02.

Artículo en Inglés | MEDLINE | ID: mdl-37284901

4.

Nivolumab versus irinotecan as third- or later-line treatment for advanced gastric cancer: a multi-center retrospective study.

Kumanishi, Ryosuke; Kadowaki, Shigenori; Mitani, Seiichiro; Matsushima, Tomohiro; Ogata, Takatsugu; Narita, Yukiya; Masuishi, Toshiki; Bando, Hideaki; Tajika, Masahiro; Yasui, Hisateru; Hara, Hiroki; Muro, Kei.

Int J Clin Oncol ; 28(6): 756-763, 2023 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-36943545

5.

Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center.

Ando, Masashi; Honda, Kazunori; Hosoda, Waki; Matsubara, Yuki; Kumanishi, Ryosuke; Nakazawa, Taiko; Ogata, Takatsugu; Nakata, Akinobu; Kodama, Hiroyuki; Masuishi, Toshiki; Narita, Yukiya; Taniguchi, Hiroya; Kadowaki, Shigenori; Muro, Kei.

Int J Clin Oncol ; 28(5): 644-653, 2023 May.

Artículo en Inglés | MEDLINE | ID: mdl-36899286

6.

[Discrepancy in Gastric Cancer Chemotherapy between the Asia and West].

Narita, Yukiya; Muro, Kei.

Gan To Kagaku Ryoho ; 50(1): 23-29, 2023 Jan.

Artículo en Japonés | MEDLINE | ID: mdl-36759981

7.

The impact of combined PD-L1 positive score on clinical response to nivolumab in patients with advanced esophageal squamous cell carcinoma.

Matsubara, Yuki; Toriyama, Kazuhiro; Kadowaki, Shigenori; Ogata, Takatsugu; Nakazawa, Taiko; Kato, Kyoko; Nozawa, Kazuki; Narita, Yukiya; Honda, Kazunori; Masuishi, Toshiki; Bando, Hideaki; Ando, Masashi; Tajika, Masahiro; Oze, Isao; Hosoda, Waki; Muro, Kei.

Esophagus ; 20(3): 524-532, 2023 07.

Artículo en Inglés | MEDLINE | ID: mdl-36595124

8.

Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition.

Sundar, Raghav; Huang, Kie-Kyon; Kumar, Vikrant; Ramnarayanan, Kalpana; Demircioglu, Deniz; Her, Zhisheng; Ong, Xuewen; Bin Adam Isa, Zul Fazreen; Xing, Manjie; Tan, Angie Lay-Keng; Tai, David Wai Meng; Choo, Su Pin; Zhai, Weiwei; Lim, Jia Qi; Das Thakur, Meghna; Molinero, Luciana; Cha, Edward; Fasso, Marcella; Niger, Monica; Pietrantonio, Filippo; Lee, Jeeyun; Jeyasekharan, Anand D; Qamra, Aditi; Patnala, Radhika; Fabritius, Arne; De Simone, Mark; Yeong, Joe; Ng, Cedric Chuan Young; Rha, Sun Young; Narita, Yukiya; Muro, Kei; Guo, Yu Amanda; Skanderup, Anders Jacobsen; So, Jimmy Bok Yan; Yong, Wei Peng; Chen, Qingfeng; Göke, Jonathan; Tan, Patrick.

Gut ; 71(7): 1277-1288, 2022 07.

Artículo en Inglés | MEDLINE | ID: mdl-34433583

9.

Cholangitis with Sphingobacterium multivorum and Acinetobacter junii bacteremia in a patient with gastric cancer: A case report.

Akazawa, Nana; Itoh, Naoya; Morioka, Hiroshi; Ogata, Takatsugu; Ishibana, Yuichi; Murakami, Hiromi; Narita, Yukiya.

J Infect Chemother ; 28(10): 1419-1423, 2022 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-35718261

10.

An observational study on nutrition status in gastric cancer patients receiving ramucirumab plus taxane: BALAST study.

Mizukami, Takuro; Miyaji, Tempei; Narita, Yukiya; Matsushima, Tomohiro; Ogura, Takashi; Miyagaki, Hiromichi; Kawabata, Ryohei; Horie, Yoshiki; Kawaguchi, Takashi; Muro, Kei; Hara, Hiroki; Yamaguchi, Takuhiro; E Nakajima, Takako.

Future Oncol ; 17(19): 2431-2438, 2021 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-33764163

11.

REVIVE study: a prospective observational study in chemotherapy after nivolumab therapy for advanced gastric cancer.

Narita, Yukiya; Shoji, Hirokazu; Kawai, Sadayuki; Mizukami, Takuro; Nakamura, Michio; Moriwaki, Toshikazu; Yamanaka, Takeharu; Sunakawa, Yu; Kawakami, Hisato; Nishina, Tomohiro; Misumi, Toshihiro; Muro, Kei.

Future Oncol ; 17(8): 869-875, 2021 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-32954810

12.

A triplet combination of FOLFOXIRI plus cetuximab as first-line treatment in RAS wild-type, metastatic colorectal cancer: a dose-escalation phase Ib study.

Kadowaki, Shigenori; Masuishi, Toshiki; Ura, Takashi; Sugiyama, Keiji; Mitani, Seiichiro; Narita, Yukiya; Taniguchi, Hiroya; Muro, Kei.

Int J Clin Oncol ; 26(4): 701-707, 2021 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-33386556

13.

Phase I Study of Alternate-Day Administration of S-1, Oral Leucovorin, and Bevacizumab for Refractory Metastatic Colorectal Cancer.

Masuishi, Toshiki; Taniguchi, Hiroya; Komori, Azusa; Mitani, Seiichiro; Narita, Yukiya; Kadowaki, Shigenori; Ura, Takashi; Ando, Masashi; Muro, Kei.

Oncologist ; 25(11): e1614-e1620, 2020 11.

Artículo en Inglés | MEDLINE | ID: mdl-32490554

14.

A Prospective Trial Evaluating the Safety of a Shortened Infusion of Ramucirumab in Patients with Gastrointestinal Cancer.

Hashimoto, Naoya; Mitani, Seiichiro; Taniguchi, Hiroya; Narita, Yukiya; Kato, Kyoko; Masuishi, Toshiki; Kadowaki, Shigenori; Onishi, Sachiyo; Tajika, Masahiro; Takahashi, Shinji; Shimomura, Kazuhiro; Takahata, Chihoko; Hotta, Eri; Kobara, Makiko; Muro, Kei.

Oncologist ; 24(2): 159-e66, 2019 02.

Artículo en Inglés | MEDLINE | ID: mdl-30305415

15.

Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan.

Kondoh, Chihiro; Kadowaki, Shigenori; Komori, Azusa; Narita, Yukiya; Taniguchi, Hiroya; Ura, Takashi; Ando, Masashi; Muro, Kei.

Gastric Cancer ; 21(6): 1050-1057, 2018 11.

Artículo en Inglés | MEDLINE | ID: mdl-29658055

16.

Efficacy of Second-Line Bevacizumab-Containing Chemotherapy for Patients with Metastatic Colorectal Cancer following First-Line Treatment with an Anti-Epidermal Growth Factor Receptor Antibody.

Hasegawa, Hiroko; Taniguchi, Hiroya; Mitani, Seiichiro; Masuishi, Toshiki; Komori, Azusa; Narita, Yukiya; Kadowaki, Shigenori; Ura, Takashi; Ando, Masashi; Yatabe, Yasushi; Muro, Kei.

Oncology ; 92(4): 205-212, 2017.

Artículo en Inglés | MEDLINE | ID: mdl-28142137

17.

Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer.

Komori, Azusa; Taniguchi, Hiroya; Hamauchi, Satoshi; Masuishi, Toshiki; Kito, Yosuke; Narita, Yukiya; Tsushima, Takahiro; Ishihara, Makoto; Todaka, Akiko; Tanaka, Tsutomu; Yokota, Tomoya; Kadowaki, Shigenori; Machida, Nozomu; Ura, Takashi; Fukutomi, Akira; Ando, Masashi; Onozawa, Yusuke; Tajika, Masahiro; Yasui, Hirofumi; Muro, Kei; Mori, Keita; Yamazaki, Kentaro.

Oncology ; 93(5): 329-335, 2017.

Artículo en Inglés | MEDLINE | ID: mdl-28866662

18.

Immunotherapy for gastroenterological cancer.

Narita, Yukiya; Muro, Kei.

Nihon Rinsho ; 75(2): 229-233, 2017 02.

Artículo en Japonés | MEDLINE | ID: mdl-30562857

19.

A short interval between bevacizumab and anti-epithelial growth factor receptor therapy interferes with efficacy of subsequent anti-EGFR therapy for refractory colorectal cancer.

Taniguchi, Hiroya; Komori, Azusa; Narita, Yukiya; Kadowaki, Shigenori; Ura, Takashi; Andoh, Masashi; Yatabe, Yasushi; Komori, Koji; Kimura, Kenichi; Kinoshita, Takashi; Muro, Kei.

Jpn J Clin Oncol ; 46(3): 228-33, 2016 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-26759349

20.

Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis.

Nomura, Motoo; Oze, Isao; Kodaira, Takeshi; Abe, Tetsuya; Komori, Azusa; Narita, Yukiya; Masuishi, Toshiki; Taniguchi, Hiroya; Kadowaki, Shigenori; Ura, Takashi; Andoh, Masashi; Tachibana, Hiroyuki; Uemura, Norihisa; Tajika, Masahiro; Niwa, Yasumasa; Muto, Manabu; Muro, Kei.

Int J Clin Oncol ; 21(5): 890-898, 2016 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-26980212

Portal de Búsqueda de la BVS

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: